Biopharma News : Biopharma and Pharma news from all around the world :
- AHF: The G20 Manifesto Calls on Leaders to Vaccinate Our World!
- ReCode Therapeutics to Present Preclinical Data from mRNA-Based Program for Primary Ciliary Dyskinesia at the 2021 PCD on the Move Virtual Scientific Conference
- Acorda Second Quarter 2021 Update: Webcast/Conference Call Scheduled for August 5, 2021
- GEHA Extends Vaccination Incentive Program to Encourage U.S. COVID-19 Vaccinations
- NIH Advances ACTIV-5/BET-B Trial Evaluating Lenzilumab from a Phase 2 Exploratory Study to a Phase 2/3 Study for the Treatment of COVID-19
- Global CBD-infused Products Market (2020 to 2028) – by Source, Type, and Distribution Channel – ResearchAndMarkets.com
- Global Contraceptives Market Forecast to 2028 – COVID-19 Impact and Analysis – ResearchAndMarkets.com
- Innovative Community Oncology Practices Selects Deep Lens’ VIPER™ as Preferred Clinical Trial Matching Solution for Network
- Worldwide In-vitro Transcription Templates Industry to 2030 – by Disease, Treatment, Research Stage, End-user and Region – ResearchAndMarkets.com
- Worldwide Targeted Therapeutics Industry to 2031 – by Type, Application, Distribution Channel and Region – ResearchAndMarkets.com
- Insights on the Downstream Processing Global Market to 2030 – Featuring Thermo Fisher Scientific, 3M and Danaher Among Others – ResearchAndMarkets.com
- Global Lyophilized Injectable Market (2021 to 2031) – Industry Analysis, Size, Share, Growth, Trends and Forecasts – ResearchAndMarkets.com
- Virpax® Pharmaceuticals Strengthens Board of Directors with the Appointment of Gerald W. Bruce and Michael F. Dubin, CPA to its Board
- Cyclo Therapeutics Announces New Positive Safety and Efficacy Data from Ongoing Phase 1 Open-Label Extension Study of Trappsol® Cyclo™ for the Treatment of Niemann-Pick Disease Type C1
- Oligomerix Presents Preclinical Data Showing Efficacy of Differentiated Approach Targeting Tau in Models of Alzheimer’s Disease and Related Tauopathies
- Schrödinger to Host Conference Call to Discuss Second Quarter 2021 Financial Results
- Imago BioSciences Receives Orphan Designation From European Medicines Agency for Bomedemstat for the Treatment of Essential Thrombocythemia
- New Surrozen to Trade on Nasdaq as “SRZN”
- Adaptive Phage Therapeutics Appoints Robert J. Hopkins, MD, MPH & TM, FACP, FIDSA, to Chief Medical Officer
- Astellas and Minovia Therapeutics Announce Strategic Collaboration for Novel Mitochondrial Cell Therapy Programs
- HUMIRA (Adalimumab) Biosimilars Report 2021: Focus on Approved & Launched, Investigational & Research Use, Inactive/Terminated/Withdrawn, Industry/Non-Industry Partnerships – ResearchAndMarkets.com
- ENYO Pharma Announces 16 Weeks Vonafexor (EYP001) Top-Line Interim Results from Two on-going Phase 2a Studies in Chronic Hepatitis B Patients
- Bristol Myers Squibb Receives European Commission Approval for Opdivo (nivolumab) as Adjuvant Treatment for Esophageal or Gastroesophageal Junction Cancer Patients with Residual Pathologic Disease Following Chemoradiotherapy
- Global Coronavirus (COVID-19) Vaccine Market to 2026 By Infection Type, Vaccine Type, Product Type, Route of Administration, Patient Type, End User, Region – ResearchAndMarkets.com
- ImmunoGen Reports Recent Progress and Second Quarter 2021 Financial Results
- Global Monoclonal Antibodies (MAbS) Market Report 2021-2030: COVID-19 Impact and Recovery – ResearchAndMarkets.com
- Global Single-Use Bioprocessing Market Industry Trends, Growth Opportunities and Forecast: 12% CAGR Forecast During 2021-2026 – ResearchAndMarkets.com
- Takeda Delivers Solid First Quarter FY2021 Results, Positioning Company to Accelerate Topline Growth and Continued Pipeline Progress
- STAPLES Center Partners With County of Los Angeles and Fulgent to Provide Free COVID-19 Vaccinations to Community and Concertgoers on 7 Upcoming Nights
- Tenaya Therapeutics Announces Pricing of Upsized Initial Public Offering
Biotech – Biopharma News!
- MediClin AG: The demand for non-corona-induced medical and therapeutic measures has been increasing since mid-2021
- Polyphor to extend period for its strategic evaluation by up to four weeks
- Fresenius Medical Care AG & Co. KGaA reports results in line with expectations for the second quarter and confirms 2021 outlook
- Cosmo Half-Year Report 2021
- Invitation: Straumann Group 2021 half-year financial results webcast
- SYNLAB: SYNLAB and AXA Partners enter a partnership to enhance safe travel this summer
- Topas Therapeutics Extends Series B, Raising Total of €40 Million (~$ 48 Million) in this Round
- Cassiopea Announces Results for First Half of 2021
- MorphoSys AG Reports Second Quarter and First Half 2021 Results
- Medacta Expands Hip Revision Portfolio, Unveiling Cutting-Edge Implants for Acetabulum and Femur
- Vitruvia Medical AG: Successful certification for the reprocessing of ‘critical C’ devices – Vitruvia Medical now also providing circular systems for highest risk-level medical devices
- BRAIN Biotech AG: Sartorius and BRAIN jointly researching and adapting novel CRISPR Cas-nucleases
- APONTIS PHARMA reports accelerated growth in first half of 2021 – Single Pill revenues +83% to EUR 14.0 million
- Relief Reports that its U.S. Collaboration Partner has Announced Emergency Use Authorization of Aviptadil in Nation of Georgia
- Relief and AdVita Close Definitive Agreement for Relief to Acquire All Outstanding Shares of AdVita
- Half Year Results Stronger than Expected; Eckert & Ziegler Increases Profit Forecast by approximately 20%
- aap: Significant sales increases in Q2 (+74%) and H1 (+37%) underline growth targets for FY/2021; USA for first time with EUR 1 million sales quarter
- Ad-hoc: MorphoSys AG to update financial guidance for 2021 and reduce financial liabilities
- SYNLAB integrates Gruppo Tronchet into its international diagnostics network, consolidating its number one position in Italy and further strengthening its service offering
- Cosmo Pharmaceuticals Announces Cassiopea SpA’s Signing of License and Supply Agreements for Winlevi® in US and Canada
- Relief Therapeutics Announces CHF 15 Million Private Placement
- Cassiopea SpA and Sun Pharma Announce Signing of License and Supply Agreements for Winlevi® (clascoterone cream 1%) in US and Canada
- IGEA ALL EQUITY OFFER TO BLUE SKY NATURAL RESOURCES LTD NOW UNCONDITIONAL AS TO ACCEPTANCES
- Abivax announces the pricing of its oversubscribed capital increase of EUR 60m and convertible bonds of EUR 25m, totaling eur 85m new financing
- Lonza Reports Strong Momentum in H1 2021, with 14.7% CER Sales Growth and 33.3% CORE EBITDA Margin
- Relief Reports that its U.S. Collaboration Partner has Announced Successful Commercial Formulation for Aviptadil
- Abivax capital increase and convertible bonds issue to qualified investors for an aggregate amount of approximately EUR 80m
- Relief Announces Issuance of Shares from Authorized Capital as Approved by 2021 Annual General Meeting
- Invitation to MorphoSys’ Second Quarter and First Half 2021 Results Conference Call on July 29, 2021
- STRATEC POSTS PRELIMINARY FIGURES FOR THE FIRST HALF AND PUBLISHES NEW SALES GUIDANCE FOR THE 2021 FINANCIAL YEAR
- Press news Biocartis Group NV: Fire Incident at Biocartis Warehouse in Mechelen, Belgium
- ECMOHO Limited Announces Proposed Underwritten Public Offering of American Depositary Shares
- Small Pharma Reports First Fiscal Quarter 2021 Highlights
- Sarepta Therapeutics Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
- Healthy Extracts Launches New Corporate Brand Awareness Campaign Following Recent Launch of Breakthrough Nutraceutical Formulation, Ultimate Brain Nutrients ACTIVATE™
- Spero Therapeutics Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
- Baudax Bio Announces Date of Reconvened Special Meeting
- Lotus Reports Third Fiscal Quarter of 2021
- Zomedica Announces 2021 Annual Meeting Results
- Jushi Holdings Inc. Receives ~$14.4 Million Interim Arbitration Award
- EssilorLuxottica : Publication of the 2021 Interim Financial Report
- Rani Therapeutics Announces Pricing of Initial Public Offering
- ALK and Grandpharma team up to market the first adrenaline autoinjector in China
- Ocugen to Host Conference Call on Friday, August 6 at 8:30 a.m. ET to Discuss Second Quarter 2021 Financial Results and Provide Business Update
- ECMOHO Limited Achieves Single-Event Single-Brand Sales Volume of RMB 2.4 Million by Utilizing “Golden” Social Media Opportunity
- Clubhouse Media Group Inc. (OTC: CMGR) Forging Future of Influencer Media and Marketing
- Core One’s Dr. Robert E.W. Hancock to Host Virtual Townhall Webcast and Present on Proprietary Biosynthesized Psilocybin Wednesday, August 4, 2021
- Nexstim Has Received an Order for an NBT® System with SmartFocus® TMS from a New Customer in the United States
- EssilorLuxottica’s second quarter & first half 2021 results : Revenue acceleration, margin expansion, record cash flow & 2021 outlook improved
- Immuneering Announces Pricing of Upsized Initial Public Offering
- RxSight, Inc. Announces Pricing of Initial Public Offering
- Junshi Biosciences Announces Acceptance by NMPA of Supplemental New Drug Application for Toripalimab Plus Chemotherapy as First-Line Treatment for Advanced or Metastatic Esophageal Squamous Cell Carcinoma
- Appendix 4C Quarterly Activity Report
- IGM Biosciences Announces the Appointment of Chris H. Takimoto, M.D., Ph.D., F.A.C.P., as Chief Medical Officer
- Cyclerion Therapeutics Reports Second Quarter 2021 Financial Results and Corporate Update
- Cellectis organise une conférence téléphonique pour présenter ses résultats financiers du deuxième trimestre 2021 le vendredi 6 août à 14h00 CET
- Cellectis to Hold Second Quarter 2021 Earnings Call on Friday, August 6, 2021 at 8AM EDT
- CRISPR Therapeutics Provides Business Update and Reports Second Quarter 2021 Financial Results
- Bioasis Announces Filing of Its First Quarter Financial Statements and MD&A
- Online availability of Sanofi’s half-year financial report for 2021
.
Biotech – Biopharma News!
Every day, Biotech 365 brings you information about Biotech Companies, Biopharma News, Biotech Tools, Bioinformatic tips and BioMarketplace ! To receive weekly notifications about Biopharma News and the last articles added to Biotech 365, please register to our Newsletter. And please Follow Biotech 365 on Twitter ( https://twitter.com/Biotech365 ) and LinkedIn (www.linkedin.com/company/biotech-365 ) … thanks !!!
Biotech 365 is an independent website, sharing information and news about Biotech Companies, Biotechnology, Biopharma News and Pharma News. If you want to contribute, you’re welcome! Please do not hesitate to Contact us ! Thanks !!!
Lots of very interesting and promising Biopharma Companies emerge everyday around the world. Looking for new partners? For new suppliers or clients? Biotech-365.com will present you lots of Biotech companies from all around the world and keep you informed about the last Biopharma news ! Don’t lose your time searching for new Biotech or Biopharma partners! The most interesting ones are on Biotech-365.com !
You want to propose a Biotech Company, a Biotech Tool or a Bioinformatic software to be presented on Biotech-365.com? Please use our Contact page ! Interested in becoming our partner? Please Contact us ! Thanks !!! If you want to promote your Biotech company or Biopharma Company on our website, please check our Offers! Biotech 365 brings you every day the more interesting information about Biopharma News, Biotech Companies and Biotech Tools! Enjoy them with a good coffee and share with your teammates!
Biopharma News – Pharma News
Biotech 365 : daily news about Biotech and Biopharma
Sources for this page of Biopharma News : biopharma-reporter.com and worldpharmanews and pharmatimes.com and drugs.com and fiercepharma.com and scripintelligence.com and PR Newswire and Business Wire. Please visit all this very interesting websites ! Thanks !
Biopharma News – Pharma News
Biopharma News – Pharma News